Financials

Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4935
BRTX
BioRestorative Therapies, Inc. - Common Stock
0.20 USD-4.76%-9.09%-20.00%-89.25%5.10 M USD
4939
MLEC
Moolec Science SA - Ordinary Shares
6.80 USD0.00%-2.72%-5.29%+389.21%4.94 M USD
4947
ADXN
Addex Therapeutics Ltd - American Depositary Shares
3.84 USD-0.26%-16.34%-33.79%-52.53%4.73 M USD
4950
CLGN
CollPlant Biotechnologies Ltd. - Ordinary Shares
0.36 USD+24.14%+9.09%+12.50%-86.05%4.61 M USD

Frequently asked questions about EVOGENE LTD.

What is the EVOGENE LTD. stock price today?

The current price of EVOGENE LTD. (EVGN) is 0.55. Over the past 24 hours, the stock has changed by +1.85%. Follow the EVGN chart for real-time price dynamics.

What is the stock ticker of EVOGENE LTD.?

EVOGENE LTD. trades under the ticker EVGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is EVOGENE LTD. stock going up?

EVGN has changed by -3.51% over the last week, +7.84% over the last month, and -56.00% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of EVOGENE LTD.?

EVOGENE LTD. currently has a market capitalization of 4.8 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

How many employees does EVOGENE LTD. have?

As of the latest available data, EVOGENE LTD. has 52 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy EVOGENE LTD. stock?

You can buy EVOGENE LTD. (EVGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in EVOGENE LTD. stock?

Investing in EVOGENE LTD. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EVGN chart and related analysis on metatrader.com as part of your research.

Evogene Ltd. - Ordinary Shares

Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture.

News